Prospective Randomized, Controlled Trial for Treatment of Intraventricular Hemorrhage
IVH
A Prospective Randomized, Controlled Trial for Treatment of Intraventricular Hemorrhage: External Ventricular Drainage and Intraventricular Thrombolysis vs. External Ventricular Drainage and Endoscopic Evacuation
1 other identifier
interventional
34
1 country
1
Brief Summary
Intraventricular hemorrhage comprises about 15% of the 500,000 strokes that occur annually in the United States. In the emergent setting, patients with obstructive hydrocephalus are routinely treated with placement of an external ventricular drain. This study will compare the effect of external ventricular drainage plus intraventricular thrombolysis versus external ventricular drainage plus endoscopic evacuation on neurologic outcomes for patients with hydrocephalus from intraventricular hemorrhage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 5, 2010
CompletedFirst Posted
Study publicly available on registry
February 8, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedJune 27, 2011
January 1, 2010
4 years
February 5, 2010
June 24, 2011
Conditions
Study Arms (2)
External Ventricular drainage, Intraventricular Thrombolysis
OTHERExternal Ventricular Drainage and Endoscopic Evacuation
OTHERInterventions
patients will be administered a total of six doses of rt-PA (each 1 mg/ml) through the external ventricular drain every eight hours.
In the operating room under general anesthesia, the external ventricular drain will be removed and the burr hole enlarged to allow for entry of the endoscope. The neuroscope will be introduced through the burr hole down the prior external ventricular drain tract into the ipsilateral ventricle. utilizing a standard technique combining gentle aspiration, continuous irrigation, and grasping forceps,the intraventricular hematoma will be evacuated. After the evacuation the endoscope will be removed and an external ventricular drain will be reattached to a closed system and permitted to drain post-operatively.
Eligibility Criteria
You may qualify if:
- Age 18-75
- Radiographic evidence of intraventricular hemorrhage with hydrocephalus
- Admission Glasgow Coma Scale ≥ 5 (motor score ≥ 2)
- Placement of an external ventricular drain with an opening pressure \>20 mm Hg
You may not qualify if:
- Intraventricular hemorrhage secondary to cerebral aneurysm, arteriovenous malformation, or tumor
- Coagulopathy (Platelet count \<100,000, International normalized ratio \>1.5. Reversal of warfarin is permitted.)
- Age \<18 or \>75
- Pregnancy (positive pregnancy test)
- Clotting disorders
- Medical contraindications to administration of general anesthesia as determined by the attending anesthesiologist
- Medical contraindications to surgery as determined by the attending neurosurgeon
- Contraindication to recombinant tissue plasminogen activator administration:
- Evidence of enlargening intracranial hemorrhage as evidenced by an increase in intracranial hemorrhage volume (\>5 ml) on CT obtained after EVD placement
- Internal bleeding, involving retroperitoneal sites, or the gastrointestinal, genitourinary, or respiratory tracts
- Superficial or surface bleeding, observed at vascular puncture and access sites (e.g. venous cutdowns, arterial punctures) or site of recent surgical intervention
- Evidence of cerebrospinal infection by Gram stain or culture
- Advanced directive indicating Do Not Resuscitate or Do Not Intubate status
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Albany Medical Center
Albany, New York, 12208, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 5, 2010
First Posted
February 8, 2010
Study Start
January 1, 2010
Primary Completion
January 1, 2014
Study Completion
January 1, 2014
Last Updated
June 27, 2011
Record last verified: 2010-01